Ablymico
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ablymico, covering 2026-08-25 to 2026-08-25. Get the full timeline:
Most recent: EMA Authorised: Ablymico (liraglutide) — STADA Arzneimittel AG
1 regulatory and trial event tracked for Ablymico, covering 2026-08-25 to 2026-08-25. Get the full timeline:
Most recent: EMA Authorised: Ablymico (liraglutide) — STADA Arzneimittel AG